Global Myopia and Presbyopia Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
상품코드:1969858
리서치사:Value Market Research
발행일:2026년 02월
페이지 정보:영문 112 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
근시 및 노안 치료 시장 규모는 2025년 275억 1,000만 달러에서 2026-2034년 CAGR 9.27%로 성장하여 2034년에는 611억 달러에 달할 것으로 예측됩니다.
세계 근시 및 노안 치료 시장은 전 연령층에서 시각 장애를 경험하는 사람들이 증가함에 따라 꾸준히 성장하고 있습니다. 스크린 사용 시간 증가, 디지털 기기 사용, 라이프스타일의 변화는 어린이와 젊은 성인의 근시 유병률 증가에 기여하고 있습니다. 동시에 전 세계적으로 고령화가 진행되면서 노안치료에 대한 수요가 증가하고 있습니다. 이러한 인구통계학적 요인과 라이프스타일 요인이 결합하여 세계 시장 확대를 지속적으로 뒷받침하고 있습니다.
주요 성장 요인으로는 교정용 렌즈, 레이저 수술, 의약품 점안제의 기술 발전이 꼽힙니다. 최소침습 수술과 개인 맞춤형 시력교정 솔루션의 혁신으로 더 많은 환자들이 치료를 선택하고 있습니다. 조기 안과 검진 및 예방적 안과 진료에 대한 인식 개선도 치료 도입률 증가에 기여하고 있습니다. 또한, 신흥 경제국의 안과 클리닉 및 안과 의료 서비스에 대한 접근성 개선이 시장 성장을 뒷받침하고 있습니다.
향후 첨단 콘택트렌즈, 스마트 글래스, 새로운 약물요법에 대한 지속적인 연구가 시장에 도움이 될 것으로 예측됩니다. 기업들은 아이들의 근시 진행을 늦추는 장기적인 해결책에 투자하고 있습니다. 원격 안과 진료(텔레옵토메트리)와 디지털 안과 검진 도구의 확대로 접근성은 더욱 향상될 것입니다. 눈 건강이 우선순위로 떠오르면서 향후 몇 년 동안 시장은 강력하고 지속적인 성장을 이룰 것으로 예측됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 근시 및 노안 치료 시장 : 근시 치료 유형별
제5장 세계의 근시 및 노안 치료 시장 : 노안 치료법 유형별
제6장 세계의 근시 및 노안 치료 시장 : 지역별
제7장 경쟁 구도
제8장 기업 개요
LSH
영문 목차
영문목차
The Myopia and Presbyopia Treatment Market size is expected to reach USD 61.10 Billion in 2034 from USD 27.51 Billion (2025) growing at a CAGR of 9.27% during 2026-2034.
The Global Myopia and Presbyopia Treatment Market is growing steadily due to the rising number of people experiencing vision problems across all age groups. Increasing screen time, digital device usage, and changing lifestyles are contributing to a higher prevalence of myopia among children and young adults. At the same time, the aging population worldwide is driving demand for presbyopia treatments. This combination of demographic and lifestyle factors is supporting consistent market expansion globally.
Key growth drivers include technological advancements in corrective lenses, laser surgeries, and pharmaceutical eye drops. Innovations in minimally invasive procedures and customized vision correction solutions are attracting more patients. Growing awareness about early eye testing and preventive eye care is also increasing treatment adoption. In addition, better access to ophthalmology clinics and eye care services in emerging economies is supporting market growth.
In the future, the market is expected to benefit from ongoing research in advanced contact lenses, smart glasses, and novel drug therapies. Companies are investing in long-term solutions that slow myopia progression in children. The expansion of tele-optometry and digital eye screening tools will further enhance accessibility. As eye health becomes a priority, the market is projected to witness strong and sustainable growth in the coming years.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Myopia Treatment Type
Corrective
Surgical
Drugs
By Presbyopia Treatment Type
Prescription Lenses
Contact Lenses
Intraocular Lenses
Refractive Surgery
COMPANIES PROFILED
Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Johnson Johnson Vision, Essilor Ltd, Zeiss International, Alcon Vision LLC, Bausch Lomb Incorporated, HaagStreit UK, Topcon Corporation
We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.4.1 Standards & Compliance
3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints
3.5.3 Market Opportunities
3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY MYOPIA TREATMENT TYPE 2022-2034 (USD MN)
4.1. Market Analysis, Insights and Forecast Myopia Treatment Type
4.2. Corrective Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY PRESBYOPIA TREATMENT TYPE 2022-2034 (USD MN)
5.1. Market Analysis, Insights and Forecast Presbyopia Treatment Type
5.2. Prescription Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Contact Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Intraocular Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Refractive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)
6.1. Regional Outlook
6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
6.2.1 By Myopia Treatment Type
6.2.2 By Presbyopia Treatment Type
6.2.3 United States
6.2.4 Canada
6.2.5 Mexico
6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
6.3.1 By Myopia Treatment Type
6.3.2 By Presbyopia Treatment Type
6.3.3 United Kingdom
6.3.4 France
6.3.5 Germany
6.3.6 Italy
6.3.7 Russia
6.3.8 Rest Of Europe
6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
6.4.1 By Myopia Treatment Type
6.4.2 By Presbyopia Treatment Type
6.4.3 India
6.4.4 Japan
6.4.5 South Korea
6.4.6 Australia
6.4.7 South East Asia
6.4.8 Rest Of Asia Pacific
6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
6.5.1 By Myopia Treatment Type
6.5.2 By Presbyopia Treatment Type
6.5.3 Brazil
6.5.4 Argentina
6.5.5 Peru
6.5.6 Chile
6.5.7 South East Asia
6.5.8 Rest of Latin America
6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
6.6.1 By Myopia Treatment Type
6.6.2 By Presbyopia Treatment Type
6.6.3 Saudi Arabia
6.6.4 UAE
6.6.5 Israel
6.6.6 South Africa
6.6.7 Rest of the Middle East And Africa
Chapter 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments
7.2. Company Categorization
7.3. Supply Chain & Channel Partners (based on availability)
7.4. Market Share & Positioning Analysis (based on availability)
7.5. Vendor Landscape (based on availability)
7.6. Strategy Mapping
Chapter 8. COMPANY PROFILES OF GLOBAL MYOPIA AND PRESBYOPIA TREATMENT INDUSTRY